These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36277729)

  • 1. Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease.
    Xiao X; Zhang J; Ji S; Qin C; Wu Y; Zou Y; Yang J; Zhao Y; Yang Q; Liu F
    Front Endocrinol (Lausanne); 2022; 13():1026995. PubMed ID: 36277729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
    Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
    BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione Peroxidase 4 Is a Predictor of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus.
    Wang YH; Chang DY; Zhao MH; Chen M
    Oxid Med Cell Longev; 2022; 2022():2948248. PubMed ID: 36275902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting energy expenditure based on equation estimation can predict renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease.
    Xiao X; Ji S; Zhang J; Kang D; Liu F
    Ren Fail; 2023; 45(2):2289487. PubMed ID: 38073123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease.
    Duan S; Sun L; Zhang C; Wu L; Nie G; Huang Z; Xing C; Zhang B; Yuan Y
    Int Immunopharmacol; 2021 Apr; 93():107413. PubMed ID: 33524800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
    Ren X; Wang W; Cao H; Shao F
    Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus.
    Ren H; Zhao L; Zou Y; Wang Y; Zhang J; Wu Y; Zhang R; Wang T; Wang J; Zhu Y; Guo R; Xu H; Li L; Cooper ME; Liu F
    Ren Fail; 2021 Dec; 43(1):477-487. PubMed ID: 33685340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of plasma NT-proBNP level and progression of diabetic kidney disease.
    Zhao Y; Zhao L; Wang Y; Zhang J; Ren H; Zhang R; Wu Y; Zou Y; Tong N; Liu F
    Ren Fail; 2023 Dec; 45(1):2158102. PubMed ID: 36820611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
    Shimizu M; Furuichi K; Toyama T; Yamanouchi M; Hoshino J; Kitajima S; Hara A; Iwata Y; Sakai N; Yuzawa Y; Kitamura H; Sato H; Shibagaki Y; Suzuki Y; Uesugi N; Ueda Y; Kohagura K; Samejima K; Tsuruya K; Nishi S; Nishino T; Makino H; Matsuo S; Ubara Y; Yokoyama H; Wada T;
    J Diabetes Investig; 2023 Nov; 14(11):1268-1278. PubMed ID: 37483063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the relationship between lipoprotein (a) and diabetic kidney disease.
    Wang A; Zhang S; Li Y; Zhu F; Xie B
    J Diabetes Complications; 2023 Jan; 37(1):108378. PubMed ID: 36549039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy.
    Zhang J; Zhang R; Wang Y; Li H; Han Q; Wu Y; Wang T; Liu F
    J Diabetes Res; 2019; 2019():7825804. PubMed ID: 30911552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-expression of FABP4 in Tubules is a Risk Factor for Poor Prognosis in DKD Patients.
    Huang Y; Cui X; Li Z; Yuan S; Han Y; Xu X; Fu X; Shi K; Zhang Z; Wei J; Xia S; Xiao Y; Xue S; Sun L; Liu H; Zhu X
    Curr Med Chem; 2024; 31(22):3436-3446. PubMed ID: 38299395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus.
    Zhang J; Wang Y; Zhang R; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F
    Diabetes Res Clin Pract; 2018 Jul; 141():1-9. PubMed ID: 29684616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.